Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy - PubMed
- ️Tue Nov 01 2005
Review
Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy
Kuan-Yeh Lee et al. Hum Vaccin Immunother. 2014.
Abstract
HIV-infected patients remain at higher risk for pneumococcal disease than the general population despite immune reconstitution and suppression of HIV replication with combination antiretroviral therapy. Vaccination with 23-valent pneumococcal polysaccharide vaccine (PPV23) composed of T-cell-independent antigens has been recommended to reduce the risk of pneumococcal disease in HIV-infected adults. However, given the heterogeneity of study design, execution and subjects enrolled, studies examining serological responses to PPV23 yielded conflicting results and observational studies of clinical effectiveness only provided moderate evidence to support the routine use of PPV23 in HIV-infected adults. Pneumococcal conjugate vaccine (PCV), with conjugation of the capsular polysaccharide to a protein carrier, is more immunogenic than PPV23 and has been demonstrated to protect against pneumococcal disease in HIV-infected children and recurrent invasive pneumococcal disease in HIV-infected adolescents and adults. Guidelines have recently been revised to recommend that HIV-infected patients aged 19 y or older receive one dose of 13-valent pneumococcal conjugate vaccine (PCV13) followed by a booster vaccination with PPV23. In this paper, we review the studies using different vaccination strategies to improve immunogenicity among HIV-infected adult patients.
Keywords: ACIP, Advisory Committee on Immunization Practices; AIDS; ART, antiretroviral therapy; DHHS, Department of Health and Human Services; EACS, European AIDS Clinical Society; ELISA, enzyme-linked immunosorbent assay; GMT, geometric mean titer; IPD, invasive pneumococcal disease; NA, not available; OPA, opsonophagocytic activity; PCV, pneumococcal conjugate vaccine; PCV13, 13-valent pneumococcal conjugate vaccine; PCV7, 7-valent pneumococcal conjugate vccine; PPV, pneumococcal polysaccharide vaccine; PPV23, 23-valent pneumococcal polysaccharide vaccine; PVL, plasma HIV RNA load; Streptococcus pneumoniae; TLR, toll-like receptor; cART, combination antiretroviral therapy; immunodeficiency; immunogenicity; invasive pneumococcal disease; pneumococcal conjugate vaccine; pneumococcal disease; pneumococcal polysaccharide vaccine.
Similar articles
-
Ho YL, Brandão AP, de Cunto Brandileone MC, Lopes MH. Ho YL, et al. Vaccine. 2013 Aug 20;31(37):4047-53. doi: 10.1016/j.vaccine.2013.04.065. Epub 2013 May 16. Vaccine. 2013. PMID: 23684823 Clinical Trial.
-
Jackson LA, Gurtman A, Rice K, Pauksens K, Greenberg RN, Jones TR, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Jackson LA, et al. Vaccine. 2013 Aug 2;31(35):3585-93. doi: 10.1016/j.vaccine.2013.05.010. Epub 2013 May 18. Vaccine. 2013. PMID: 23688527 Clinical Trial.
-
Durando P, Faust SN, Fletcher M, Krizova P, Torres A, Welte T. Durando P, et al. Clin Microbiol Infect. 2013 Oct;19 Suppl 1:1-9. doi: 10.1111/1469-0691.12320. Clin Microbiol Infect. 2013. PMID: 24083785 Review.
-
Madhi SA, Cohen C, von Gottberg A. Madhi SA, et al. Vaccine. 2012 Sep 7;30 Suppl 3:C21-7. doi: 10.1016/j.vaccine.2012.05.055. Vaccine. 2012. PMID: 22939016 Review.
Cited by
-
Gaultier GN, McCready W, Ulanova M. Gaultier GN, et al. BMC Immunol. 2019 Nov 12;20(1):41. doi: 10.1186/s12865-019-0325-9. BMC Immunol. 2019. PMID: 31718534 Free PMC article.
-
Marcus JL, Baxter R, Leyden WA, Muthulingam D, Yee A, Horberg MA, Klein DB, Towner WJ, Chao CR, Quesenberry CP Jr, Silverberg MJ. Marcus JL, et al. AIDS Patient Care STDS. 2016 Oct;30(10):463-470. doi: 10.1089/apc.2016.0165. AIDS Patient Care STDS. 2016. PMID: 27749111 Free PMC article.
-
Tsachouridou O, Skoura L, Zebekakis P, Margariti A, Georgiou A, Bougiouklis D, Pilalas D, Galanos A, Daniilidis M, Metallidis S. Tsachouridou O, et al. World J Virol. 2016 Nov 12;5(4):155-160. doi: 10.5501/wjv.v5.i4.155. World J Virol. 2016. PMID: 27878102 Free PMC article.
-
Living with HIV and Getting Vaccinated: A Narrative Review.
De Vito A, Colpani A, Trunfio M, Fiore V, Moi G, Fois M, Leoni N, Ruiu S, Babudieri S, Calcagno A, Madeddu G. De Vito A, et al. Vaccines (Basel). 2023 Apr 25;11(5):896. doi: 10.3390/vaccines11050896. Vaccines (Basel). 2023. PMID: 37243000 Free PMC article. Review.
-
Nomah DK, Reyes-Urueña J, Llibre JM, Ambrosioni J, Ganem FS, Miró JM, Casabona J. Nomah DK, et al. Curr HIV/AIDS Rep. 2022 Feb;19(1):17-25. doi: 10.1007/s11904-021-00596-5. Epub 2022 Feb 3. Curr HIV/AIDS Rep. 2022. PMID: 35113346 Free PMC article. Review.
References
-
- Titanji K, De Milito A, Cagigi A, Thorstensson R, Grützmeier S, Atlas A, Hejdeman B, Kroon FP, Lopalco L, Nilsson A, et al. . Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108:1580-7; PMID:16645169; http://dx.doi.org/10.1182/blood-2005-11-013383 - DOI - PubMed
-
- De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, Narita M, Grutzmeier S, Sönnerborg A, Chiodi F. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103:2180-6; PMID:14604962; http://dx.doi.org/10.1182/blood-2003-07-2375 - DOI - PubMed
-
- Terpstra FG, Al BJ, Roos MT, De Wolf F, Goudsmit J, Schellekens PT, Miedema F. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Eur J Immunol 1989; 19:667-73; PMID:2567244; http://dx.doi.org/10.1002/eji.1830190415 - DOI - PubMed
-
- Hart M, Steel A, Clark SA, Moyle G, Nelson M, Henderson DC, Wilson R, Gotch F, Gazzard B, Kelleher P. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol 2007; 178:8212-20; PMID:17548660; http://dx.doi.org/10.4049/jimmunol.178.12.8212 - DOI - PubMed
-
- Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9:235-45; PMID:19319142; http://dx.doi.org/10.1038/nri2524 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical